FDA approves Moderna’s new lower-dose COVID-19 vaccine

bostonherald.com/2025/05/31/fda-approves-modernas-new-lower-dose-covid-19-vaccine

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second option.
The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It’s made in a way that…

This story appeared on bostonherald.com, 2025-05-31 21:16:31.
The Entire Business World on a Single Page. Free to Use →